Redx Pharma Plc
LSE: REDX.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Lisa Mary Whewell Anson
- Employees
- 101
- Headquarters
- Macclesfield, United Kingdom
- IPO year
- 2015
- Market cap
- £58.3M
- Website
- https://www.redxpharma.com
Loading REDX…
Loading profile data…Frequently asked questions about REDX
What does Redx Pharma Plc (REDX.L) do?
Redx Pharma Plc engages in drug discovery, pre-clinical development, and licensing activities in the United Kingdom. It discovers and develops small molecule drugs for treating anti-cancer and fibrosis targets in the areas of unmet medical needs. The company also develops RXC004, a porcupine inhibitor that is in Phase II clinical trial for targe...
Where does REDX.L trade?
Redx Pharma Plc (REDX.L) trades on the London Stock Exchange.
What sector is REDX.L in?
Redx Pharma Plc (REDX.L) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Redx Pharma Plc?
Lisa Mary Whewell Anson is the chief executive officer of Redx Pharma Plc (REDX.L).
Where is Redx Pharma Plc headquartered?
Redx Pharma Plc is headquartered in United Kingdom.
Does REDX.L pay a dividend?
Redx Pharma Plc (REDX.L) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did REDX.L go public?
Redx Pharma Plc (REDX.L) completed its initial public offering in 2015.